Name: Calamp Corp. (CAMP) News, Articles, Events & Latest Updates
Creator: Stocktwits

SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir Technologies is surging following a blowout earnings report that shattered analyst expectations for both revenue and profitability, driven by massive growth in U.S. commercial adoption and strengthened guidance. While the community is actively celebrating the stock's resilience, discussions remain polarized between investors highlighting Palantir's leadership in sovereign AI and skeptics continuing to debate the company's valuation and long-term sustainability.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is seeing intense volatility and negative sentiment following a major debt exchange that will result in shareholder dilution. Community members are divided, with many debating the strategic necessity of the move for potential future acquisitions versus frustration over continued share issuance.

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is trending as investor focus intensifies ahead of upcoming quarterly earnings, with the community actively debating whether the company's advertising recovery and AI-powered subscription growth signal a long-awaited turnaround. While some bulls are encouraged by improving profitability and speculation regarding potential buyouts or strategic partnerships, skeptics remain cautious due to historical user growth challenges and the uncertain market reception of the company's augmented reality hardware.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending as investors react to a significant revenue beat and raised guidance for BRIUMVI, fueling discussions about the company's growth trajectory and potential for future M&A activity. The community is actively debating the impact of increased R&D and manufacturing investments on short-term earnings versus the long-term value of the expanding pipeline.

Voyager Technologies, Inc. engages in the defense technology and space solutions. It operates through the following segments: Defense & National Security, Space Solutions, and Starlab Space Stations. The Defense & National Security segment consists of innovative mission-critical solutions to protect dynamic and contested domains. The Space Solutions segment consists of space infrastructure, advanced space technology, science systems and mission services. The Starlab Space Stations segment consists of a commercial space station. The company was founded by Dylan Taylor and Matthew Kuta on August 15, 2019 and is headquartered in Denver, CO.

Voyager Technologies Inc. - Ordinary Shares - Class A

Voyager Technologies is trending following a record-breaking second quarter characterized by a major earnings beat, significant revenue growth, and raised guidance driven by strong demand for space infrastructure and new AI contracts. The community is actively discussing the company's backlog surge and the potential for a multi-year growth trajectory as it scales its operations in the space-tech sector.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

AstraZeneca is trending as it officially moves its stock listing to the New York Stock Exchange, a strategic transition supported by significant investment plans in the U.S. market. Additionally, the company is drawing attention due to reports of a potential multibillion-dollar acquisition of the French biotech firm Abivax, signaling an aggressive push to expand its pipeline and strengthen its global oncology and inflammation portfolio.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

United States Oil Fund is trending as investors grapple with extreme volatility driven by conflicting signals between geopolitical escalation in the Middle East and ongoing attempts by the administration to jawbone prices lower via diplomatic announcements. The community remains deeply divided and highly skeptical, with many traders expressing frustration over the reliability of headlines, accusing insiders of market manipulation while pointing to critically low Strategic Petroleum Reserve levels as an underlying factor that may keep prices elevated despite temporary dips.

Listed Funds Trust - Roundhill Magnificent Seven ETF

Roundhill Magnificent Seven ETF

The Magnificent Seven ETF is experiencing significant volatility as investors rotate capital, closely scrutinizing hyperscaler capital expenditure and the sustainability of the AI growth trade. While some market participants express caution regarding record-high infrastructure spending, others view the recent price action as a healthy consolidation, with the community actively debating whether the group is entering a long-term corrective phase or positioning for a rebound.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is currently trending as investors position themselves ahead of the company's highly anticipated earnings report, with community sentiment split between expectations of a significant 'beat and raise' cycle and concerns over potential profit-taking or valuation concerns following recent volatility. The discussion is heavily focused on AMD's role in the broader AI infrastructure buildout and speculation on how upcoming guidance will impact its competitive standing against other semiconductor leaders.

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is under significant scrutiny as investors grapple with a bearish multi-month downtrend and growing concerns regarding consumer spending habits and menu affordability. While some investors identify the stock's multi-year low valuation as a potential long-term accumulation opportunity, community sentiment remains sharply divided between those betting on a turnaround and others who are aggressively shorting the stock, citing perceived weaknesses in the brand's competitive position and recent food quality narratives.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CRISPR Therapeutics AG (CRSP) Reports Q2 Loss, Tops Revenue Estimates

CRISPR Therapeutics (CRSP) delivered earnings and revenue surprises of +14.55% and +37.28%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

CAMP Expands Its Team as the Race to Unlock Next-Generation RNA Therapeutics Accelerates

Talent is often one of the earliest indicators of a biotechnology company's long-term ambitions. That theme was reinforced this week as CAMP4 Therapeutics (NASDAQ:CAMP) announced an inducement equity award to a newly hired employee under Nasdaq Listing Rule 5635(c)(4), a standard mechanism that allows listed companies to use equity grants as a recruiting incentive for new hires. While modest in size, an option to purchase 8,000 shares, the announcement signals continued investment in building the team behind CAMP4's clinical-stage pipeline.

New Strong Sell Stocks for July 16th

AYTU, CAMP and CRC have been added to the Zacks Rank #5 (Strong Sell) List on July 16, 2026.

CAMP4 Therapeutics Corporation (CAMP) Reports Q1 Loss, Lags Revenue Estimates

CAMP4 Therapeutics Corporation (CAMP) delivered earnings and revenue surprises of -49.53% and -22.19%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Short Interest in CAMP4 Therapeutics Corporation (NASDAQ:CAMP) Expands By 13.1%

CAMP4 Therapeutics Corporation (NASDAQ:CAMP - Get Free Report) was the target of a large increase in short interest in the month of April. As of April 15th, there was short interest totaling 468,369...

CAMP4 Therapeutics Corporation (NASDAQ:CAMP) Short Interest Down 14.2% in March

CAMP4 Therapeutics Corporation (NASDAQ:CAMP - Get Free Report) was the target of a large decrease in short interest in March. As of March 31st, there was short interest totaling 414,235 shares, a decrease of 14.2% from the March 15th total of 483,060 shares. Based on an average daily trading...

CAMP4 Therapeutics (NASDAQ:CAMP) Upgraded to "Strong-Buy" at Rodman & Renshaw

Rodman & Renshaw upgraded CAMP4 Therapeutics to a "strong-buy" rating in a research report on Tuesday...

CAMP4 Therapeutics Unveils Gene-Upregulation ASO Platform, Targets SYNGAP1 Clinic Entry in 2H

CAMP4 Therapeutics (NASDAQ:CAMP) outlined its approach to upregulating gene expression using antisense oligonucleotides (ASOs) and provided an update on its lead central nervous system (CNS) program...

CAMP4 Therapeutics Corporation (NASDAQ:CAMP) Given Average Rating of "Moderate Buy" by Analysts

CAMP4 Therapeutics Corporation (NASDAQ:CAMP - Get Free Report) has received a consensus rating of "Moderate Buy" from the six ratings firms that are presently covering the firm, Marketbeat Ratings...

Camp4 Therapeutics Earnings Review: Q4 Summary

CAMP4 Therapeutics Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a class of RNA-targeting therapeutics for upregulating gene expression and restoration of healthy protein levels to treat a broad range of genetic diseases. Its lead product candidate is CMP-002. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.

CAMP4 Therapeutics Corp.

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info